Ex vivo-model design and evaluation of the sensitivity of blast cells to chemotherapy as a way to personalize the treatment of acute myeloid leukemia

Despite continuous attempts to improve therapy, the outcomes of acute myeloid leukemia remain almost unchanged over last decades. Drugs made with a more complete understanding of the biology of acute myeloid leukemia do not equal the hopes for better prognosis. The best results are achieved only wit...

Full description

Saved in:

Bibliographic Details
Main Authors:	A. S. Polyakov, Ya. A. Noskov, Yu. V. Nikitin, V. V. Tyrenko, S. N. Kolubaeva, A. N. Bogdanov, V. N. Semelev, O. R. Petrova, S. V. Bondarchuk, D. K. Zhogolev, A. D. Zolotarev, A. V. Kovalev, Yu. E. Puchkova
Format:	Article
Language:	Russian
Published:	ABV-press 2019-07-01
Series:	Онкогематология
Subjects:	acute myeloid leukemia secondary acute myeloid leukemia ex vivo model drug sensitivity testing genotoxicity micronucleus test fluorescence activated cell sorting individualization of drug therapy
Online Access:	https://oncohematology.abvpress.ru/ongm/article/view/349
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!

Ex vivo-model design and evaluation of the sensitivity of blast cells to chemotherapy as a way to personalize the treatment of acute myeloid leukemia

Similar Items